纽约2026年3月3日 /美通社/ -- 生物制药特许权买家Royalty Pharma plc(纳斯达克代码:RPRX)宣布任命孙锶铭先生 (Kenneth Sun)为高级副总裁兼亚洲区主管,自2026年5月起生效。他将常驻香港,领导公司在亚洲的特许权业务。在加入Royalty Pharma 前,他担任摩根士丹利亚太区医疗投资银行部主管。 亚洲生物科技企业如今积极研发了多种创新治疗药物。在...
Source Link纽约2026年3月3日 /美通社/ -- 生物制药特许权买家Royalty Pharma plc(纳斯达克代码:RPRX)宣布任命孙锶铭先生 (Kenneth Sun)为高级副总裁兼亚洲区主管,自2026年5月起生效。他将常驻香港,领导公司在亚洲的特许权业务。在加入Royalty Pharma 前,他担任摩根士丹利亚太区医疗投资银行部主管。 亚洲生物科技企业如今积极研发了多种创新治疗药物。在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.